ATE285797T1 - In vivo assay zur prüfung der phänotypischen stabilität - Google Patents

In vivo assay zur prüfung der phänotypischen stabilität

Info

Publication number
ATE285797T1
ATE285797T1 AT00967443T AT00967443T ATE285797T1 AT E285797 T1 ATE285797 T1 AT E285797T1 AT 00967443 T AT00967443 T AT 00967443T AT 00967443 T AT00967443 T AT 00967443T AT E285797 T1 ATE285797 T1 AT E285797T1
Authority
AT
Austria
Prior art keywords
chondrocytes
stability
vivo assay
outcome
test
Prior art date
Application number
AT00967443T
Other languages
English (en)
Inventor
Frank Luyten
Bari Cosimo De
Accio Francesco Dell
Original Assignee
Tigenix Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tigenix Nv filed Critical Tigenix Nv
Application granted granted Critical
Publication of ATE285797T1 publication Critical patent/ATE285797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00967443T 1999-10-06 2000-10-06 In vivo assay zur prüfung der phänotypischen stabilität ATE285797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203273 1999-10-06
PCT/BE2000/000118 WO2001024833A2 (en) 1999-10-06 2000-10-06 In vivo assay for testing the phenotypic stability

Publications (1)

Publication Number Publication Date
ATE285797T1 true ATE285797T1 (de) 2005-01-15

Family

ID=8240723

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967443T ATE285797T1 (de) 1999-10-06 2000-10-06 In vivo assay zur prüfung der phänotypischen stabilität

Country Status (12)

Country Link
US (2) US7479367B1 (de)
EP (2) EP1218037B1 (de)
AT (1) ATE285797T1 (de)
AU (1) AU7764200A (de)
CA (1) CA2397610C (de)
CY (1) CY2010007I1 (de)
DE (3) DE20023659U1 (de)
DK (1) DK1218037T3 (de)
ES (2) ES2234673T3 (de)
LU (1) LU91672I2 (de)
PT (1) PT1218037E (de)
WO (1) WO2001024833A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20023659U1 (de) 1999-10-06 2005-07-07 Tigenix N.V. Molekulare Marker zum Testen der phänotypischen Stabilität von Zellpopulationen und Zellpopulationen für die autologe Transplantation
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
AU2001266915A1 (en) 2000-06-14 2001-12-24 Case Western Reserve University Probes for chondrogenesis
EP1546392A4 (de) * 2002-08-02 2006-05-24 Stratatech Corp Spezies-spezifischer dna-nachweis
NZ572055A (en) 2006-03-20 2011-11-25 Tigenix Nv Methods to maintain, improve and restore the cartilage phenotype of chondrocytes
CA2670419C (en) * 2006-11-24 2018-07-17 Tigenix N.V. Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production
CN101215565B (zh) * 2008-01-11 2011-04-27 华中农业大学 一种作为猪标记辅助选择的与免疫性状相关的分子标记的克隆及应用
GB0902793D0 (en) 2009-02-20 2009-04-08 Univ Gent GDF15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes
EP3872168A1 (de) * 2020-02-28 2021-09-01 Cline Scientific AB Chondrozytendifferenzierung
EP4200019A1 (de) 2020-08-21 2023-06-28 Genzyme Corporation Fgfr3-antikörper und verfahren zur verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5723331A (en) 1994-05-05 1998-03-03 Genzyme Corporation Methods and compositions for the repair of articular cartilage defects in mammals
US5902785A (en) 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
IL122472A (en) 1995-06-12 2003-11-23 Yeda Res & Dev Compositions of fgf9 as a specific ligand for fgfr3 and uses thereof
EP0988398A4 (de) 1997-05-21 2005-05-18 Clontech Lab Inc Nukleinsäure-arrays
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
DE20023659U1 (de) * 1999-10-06 2005-07-07 Tigenix N.V. Molekulare Marker zum Testen der phänotypischen Stabilität von Zellpopulationen und Zellpopulationen für die autologe Transplantation
PT1282690E (pt) * 1999-10-06 2005-02-28 Tigenix Nv Isolamento de celulas e sua utilizacao na reparacao de tecidos
US7482114B2 (en) 1999-10-06 2009-01-27 Tigenix N.V. In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation

Also Published As

Publication number Publication date
DE122010000021I1 (de) 2012-09-06
EP1498146A2 (de) 2005-01-19
US9089598B2 (en) 2015-07-28
CY2010007I2 (el) 2010-07-28
EP1218037B1 (de) 2004-12-29
DE20023659U1 (de) 2005-07-07
DE60017159T2 (de) 2006-05-04
EP1498146A3 (de) 2007-01-24
US20090162328A1 (en) 2009-06-25
WO2001024833A2 (en) 2001-04-12
CA2397610A1 (en) 2001-04-12
AU7764200A (en) 2001-05-10
ES2234673T3 (es) 2005-07-01
PT1218037E (pt) 2005-05-31
CA2397610C (en) 2012-07-03
DK1218037T3 (da) 2005-04-25
LU91672I2 (fr) 2010-06-02
EP1218037A2 (de) 2002-07-03
ES2488240T1 (es) 2014-08-26
DE60017159D1 (de) 2005-02-03
CY2010007I1 (el) 2010-07-28
WO2001024833A3 (en) 2001-12-20
US7479367B1 (en) 2009-01-20

Similar Documents

Publication Publication Date Title
LU91672I2 (fr) ChondroCelect
DE69927512D1 (de) Verwendung von op-1 zur herstellung einer pharmazeutischen zusammensetzung zur reparatur von nicht-gelenksknorpeldefekten eines säugers
SE9303977D0 (sv) Verfahren zur herstellung von implantatkeramikmaterial, insbesonders von hydroxylapatit aufweisenden implantatkeramikmaterial
DE69619526D1 (de) Fgf9 als spezifischer ligand für fgfr3
YU12201A (sh) Metodi, instrumenti i materijali za transplantaciju ćelija hondrocita
ZA985507B (en) Method for assessing disposable absorbent articles with improved skin dryness performance and with improved skin aeration
DE69828050D1 (de) Verfahren zur herstellung eines poly(vinyl)alkoholkryogels
ATE330000T1 (de) Verwendung von fettgewebe-abgeleiteten stromalen zellen zur differenzierung in chondrozyten und ihre verwendung zur reparatur von knorpelgewebe
DE60044793D1 (de) In-vitro Herstellung von transplantierbarem Knorpelgewebe
ATE346610T1 (de) Zusammensetzung enthaltend, ein antigen, ein th-1 induzierendes adjuvans und eine im wasser schwer lösliche aminosäure, zur verwendung in der immunisierung
ATE418620T1 (de) Sonde zur herstellung einer polymersonde, verfahren zur herstellung einer polymersonde sowie verwendung derselben
DK1130394T3 (da) In vitro-modeller af CNS-funktion og -dysfunktion
ATE356199T1 (de) Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation
DE69811505T2 (de) Verfahren und zusammensetzungen zur bekämpfung von biologischer verschmutzung unter verwendung von sulfaminsäuren
DE60034672D1 (de) Reporterverbindungen und verfahren zur bestimmung des lipidisierungsstatus einer zelle
DE59507162D1 (de) Verfahren zur Befestigung von Hängen
DE69715034D1 (de) Verfahren zur herstellung von dem anaphase-fördernden komplex
ATE455565T1 (de) Verwendung eines biologischen materials mit dreidimensionalen gerüsten aus hyaluronsäure- derivaten
DE60026272D1 (de) Verwendung eines Papillarfibroblast-spezifischen Antikörpers als Marker der Hautqualität
DK373288D0 (da) Fremgangsmaade til bestemmelse af en protetisk overflades daekning med endotel-celler
ATE303810T1 (de) In vivo färbemittel und verwendungsmethoden zur identifizierung von dysplastischem gewebe
ATE209354T1 (de) Methode zur in vitro-bestimmung der bioaktivität von erythropoietin